Immunic | 8-K: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
04:57
The Trump team will consider Orban's proposal for a Christmas ceasefire in Ukraine.
04:43
The Israeli army launched an attack on a school in the Gaza Strip, resulting in the deaths of 20 people.
04:00
According to the Palestinian official news agency, the Israeli attack on a shelter for displaced persons in Khan Younis, Gaza Strip, resulted in the death of at least 10 Palestinians.